Selected research
Industry Growth & Trends
Global Acamprosate Industry Growth and Trends Forecast to 2032
Market perspective
The global Acamprosate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Acamprosate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Acamprosate include Teva, Merck Group, Mylan, Zydus Pharmaceuticals and Glenmark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Acamprosate market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Acamprosate market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Acamprosate market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Acamprosate.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Acamprosate market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Acamprosate Market by Company
Teva
Merck Group
Mylan
Zydus Pharmaceuticals
Glenmark Pharmaceuticals
Acamprosate Segment by Type
333 mg Delayed Release Tablet
Others
Acamprosate Segment by Application
Hospital
Clinic
Others
Acamprosate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acamprosate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Acamprosate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acamprosate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Acamprosate manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Acamprosate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 333 mg Delayed Release Tablet
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Teva
- Merck Group
- Mylan
- Zydus Pharmaceuticals
- Glenmark Pharmaceuticals
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Acamprosate Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Acamprosate Sales Estimates and Forecasts (2021-2032)
- 1.3 Acamprosate Market by Type
- 1.3.1 333 mg Delayed Release Tablet
- 1.3.2 Others
- 1.4 Global Acamprosate Market Size by Type
- 1.4.1 Global Acamprosate Market Size Overview by Type (2021-2032)
- 1.4.2 Global Acamprosate Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Acamprosate Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Acamprosate Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Acamprosate Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Acamprosate Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Acamprosate Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Acamprosate Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Acamprosate Industry Trends
- 2.2 Acamprosate Industry Drivers
- 2.3 Acamprosate Industry Opportunities and Challenges
- 2.4 Acamprosate Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Acamprosate Revenue (2021-2026)
- 3.2 Global Top Players by Acamprosate Sales (2021-2026)
- 3.3 Global Top Players by Acamprosate Price (2021-2026)
- 3.4 Global Acamprosate Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Acamprosate Major Company Production Sites & Headquarters
- 3.6 Global Acamprosate Company, Product Type & Application
- 3.7 Global Acamprosate Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Acamprosate Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Acamprosate Players Market Share by Revenue in 2025
- 3.8.3 2025 Acamprosate Tier 1, Tier 2, and Tier 3
4 Acamprosate Regional Status and Outlook
- 4.1 Global Acamprosate Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Acamprosate Historic Market Size by Region
- 4.2.1 Global Acamprosate Sales in Volume by Region (2021-2026)
- 4.2.2 Global Acamprosate Sales in Value by Region (2021-2026)
- 4.2.3 Global Acamprosate Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Acamprosate Forecasted Market Size by Region
- 4.3.1 Global Acamprosate Sales in Volume by Region (2027-2032)
- 4.3.2 Global Acamprosate Sales in Value by Region (2027-2032)
- 4.3.3 Global Acamprosate Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Acamprosate by Application
- 5.1 Acamprosate Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.1.3 Others
- 5.2 Global Acamprosate Market Size by Application
- 5.2.1 Global Acamprosate Market Size Overview by Application (2021-2032)
- 5.2.2 Global Acamprosate Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Acamprosate Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Acamprosate Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Acamprosate Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Acamprosate Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Acamprosate Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Acamprosate Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Teva
- 6.1.1 Teva Company Information
- 6.1.2 Teva Business Overview
- 6.1.3 Teva Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Teva Acamprosate Product Portfolio
- 6.1.5 Teva Recent Developments
- 6.2 Merck Group
- 6.2.1 Merck Group Company Information
- 6.2.2 Merck Group Business Overview
- 6.2.3 Merck Group Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Merck Group Acamprosate Product Portfolio
- 6.2.5 Merck Group Recent Developments
- 6.3 Mylan
- 6.3.1 Mylan Company Information
- 6.3.2 Mylan Business Overview
- 6.3.3 Mylan Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Mylan Acamprosate Product Portfolio
- 6.3.5 Mylan Recent Developments
- 6.4 Zydus Pharmaceuticals
- 6.4.1 Zydus Pharmaceuticals Company Information
- 6.4.2 Zydus Pharmaceuticals Business Overview
- 6.4.3 Zydus Pharmaceuticals Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Zydus Pharmaceuticals Acamprosate Product Portfolio
- 6.4.5 Zydus Pharmaceuticals Recent Developments
- 6.5 Glenmark Pharmaceuticals
- 6.5.1 Glenmark Pharmaceuticals Company Information
- 6.5.2 Glenmark Pharmaceuticals Business Overview
- 6.5.3 Glenmark Pharmaceuticals Acamprosate Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Glenmark Pharmaceuticals Acamprosate Product Portfolio
- 6.5.5 Glenmark Pharmaceuticals Recent Developments
7 North America by Country
- 7.1 North America Acamprosate Sales by Country
- 7.1.1 North America Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Acamprosate Sales by Country (2021-2026)
- 7.1.3 North America Acamprosate Sales Forecast by Country (2027-2032)
- 7.2 North America Acamprosate Market Size by Country
- 7.2.1 North America Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Acamprosate Market Size by Country (2021-2026)
- 7.2.3 North America Acamprosate Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Acamprosate Sales by Country
- 8.1.1 Europe Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Acamprosate Sales by Country (2021-2026)
- 8.1.3 Europe Acamprosate Sales Forecast by Country (2027-2032)
- 8.2 Europe Acamprosate Market Size by Country
- 8.2.1 Europe Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Acamprosate Market Size by Country (2021-2026)
- 8.2.3 Europe Acamprosate Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Acamprosate Sales by Country
- 9.1.1 Asia-Pacific Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Acamprosate Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Acamprosate Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Acamprosate Market Size by Country
- 9.2.1 Asia-Pacific Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Acamprosate Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Acamprosate Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Acamprosate Sales by Country
- 10.1.1 South America Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Acamprosate Sales by Country (2021-2026)
- 10.1.3 South America Acamprosate Sales Forecast by Country (2027-2032)
- 10.2 South America Acamprosate Market Size by Country
- 10.2.1 South America Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Acamprosate Market Size by Country (2021-2026)
- 10.2.3 South America Acamprosate Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Acamprosate Sales by Country
- 11.1.1 Middle East and Africa Acamprosate Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Acamprosate Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Acamprosate Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Acamprosate Market Size by Country
- 11.2.1 Middle East and Africa Acamprosate Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Acamprosate Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Acamprosate Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Acamprosate Value Chain Analysis
- 12.1.1 Acamprosate Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Acamprosate Production Mode & Process
- 12.2 Acamprosate Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Acamprosate Distributors
- 12.2.3 Acamprosate Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst